amlodipine/valsartan/hct novartis 5/160/12.5 amlodipine/valsartan/hydrochlorothiazide tablet blister pack
novartis pharmaceuticals australia pty ltd - valsartan, quantity: 160 mg; hydrochlorothiazide, quantity: 12.5 mg; amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: crospovidone; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; purified talc; macrogol 4000 - amlodipine/valsartan/hct novartis is indicated only as substitution therapy for the treatment of hypertension in patients whose blood pressure is already adequately controlled on the triple combination of amlodipine, valsartan and hydrochlorothiazide taken either as three single component formulations or as dual-component formulation with a single component formulation, all components at the same dose level. treatment should not be initiated with these fixed-dose combinations (see dosage and administration).
valsartan/hydrochlorothiazide teva 160 mg/12.5 mg film-coated tablets
teva pharma b.v. - valsartan; hydrochlorothiazide - film-coated tablet - 160 mg /12.5 milligram(s) - angiotensin ii antagonists and diuretics; valsartan and diuretics
valsartan tablet, film coated
northwind pharmaceuticals, llc - valsartan (unii: 80m03yxj7i) (valsartan - unii:80m03yxj7i) - valsartan 80 mg - 1.1 hypertension valsartan tablets, usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which valsartan principally belongs. there are no controlled trials in hypertensive patients demonstrating risk reduction with valsartan tablets, usp. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee
valsartan and hydrochlorothiazide- valsartan and hydrochlorothiazide tablet, film coated
remedyrepack inc. - valsartan (unii: 80m03yxj7i) (valsartan - unii:80m03yxj7i), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - valsartan and hydrochlorothiazide tablets, usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including hydrochlorothiazide and the arb class to which valsartan principally belongs. there are no controlled trials demonstrating risk reduction with valsartan and hydrochlorothiazide tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education progra
apo-valsartan valsartan 320 mg tablet blister pack
apotex pty ltd - valsartan -
apo-valsartan valsartan 160 mg tablet blister pack
apotex pty ltd - valsartan -
apo-valsartan valsartan 80 mg tablet blister pack
apotex pty ltd - valsartan -
apo-valsartan valsartan 40 mg tablet blister pack
apotex pty ltd - valsartan -
valsartan teva 80 mg film-coated tablets
teva pharma b.v. - valsartan - film-coated tablet - 80 milligram(s) - angiotensin ii antagonists, plain; valsartan
valsartan teva 40 mg film-coated tablets
teva pharma b.v. - valsartan - film-coated tablet - 40 milligram(s) - angiotensin ii antagonists, plain; valsartan